Welcome to HIMSS

This site uses technologies such as cookies to provide a better user experience by personalising content and ads, analysing web traffic and trends, and improving site operations. We may share information about your use of the site with third parties in accordance with our Privacy Policy. By continuing to use this site you agree that we can save cookies on your device, unless you have disabled them. You can change your cookie settings at any time by visiting our Cookie Policy, but parts of our site may not function correctly without them.

Skip to main content
Home
  • Main Menu
  • Topics
    • Video
    • Provider
    • Payer
    • Pharma
    • Consumer
    • Investor

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition
Global Edition
Digital Health

Hims & Hers adds GLP-1 injections to weight loss program

The company said its drugs will be more accessible than brand-name versions thanks to a partnership with a manufacturer of generic and 503B compounded injectables.
By Jessica Hagen
May 20, 2024
01:14 pm
Share

Photo: poba/Getty Images

Direct-to-consumer virtual care company Hims & Hers is the latest digital health company to announce it will add GLP-1 medications to its offerings to assist users with weight-loss management.    

The San Francisco-based company, which launched its weight-loss program in December, said users will now have access to generic and 503B compounded injectable medications and oral medication kits for weight management, which are priced starting at $199 a month.

In a statement, the company said its medications will be more readily available than brand names like Ozempic or Wegovy thanks to a partnership with a U.S. manufacturer of generic versions of GLP-1s. 

"We’ve leveraged our size and scale to secure access to one of the highest-quality supplies of compounded GLP-1 injections available today. We’re passing that access and value along to our customers, who deserve the highest standard of clinical safety and efficacy to meet their goals, and we're doing it in a safe, affordable way that others can’t deliver," Andrew Dudum, CEO and cofounder of Hims & Hers, said in a statement. 

THE LARGER TREND

Researchers continue to evaluate the safety of GLP-1 medications for long-term use. 

One study published in the International Journal of Clinical Pharmacy revealed there is increasing data on the potential of pancreatic carcinoma associated with GLP-1 receptor agonists.

However, another study published in JAMA Network Open showed that researchers found no support for increased pancreatic cancer incidence after seven years following the start of GLP-1 treatment.  

Other companies that have added GLP-1-focused offerings to their platform include digital chronic-condition-management company Lark Health. 

Digital weight-loss company Noom announced its commercial business, Noom for Work, and national pharmacy benefit manager Liviniti were partnering to offer plan sponsors and their employees a digital GLP-1 Companion for chronic weight conditions.

Tags: 
Hims & Hers, GLP-1, weight management

More regional news

Pharmacist interacting online

Serve You Rx, Amazon Pharmacy partner for home delivery

By
Anthony Vecchione
May 02, 2025
Two people shaking hands with six others watch

DarioHealth closes up to $50M debt refinancing and more funding news

By
Jessica Hagen
May 02, 2025
Smart phone and smart watch

Oura and Google Fitbit partner with academia and others to battle opioid disorder

By
Anthony Vecchione
May 02, 2025
Share

Top Story

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder

Editor's Pick

23andMe files for bankruptcy, CEO Wojcicki resigns
Q&A: Oura appoints its first chief medical officer
First blood pressure management system integrated with DeepSeek in Hong Kong
Emirates will offer inflight telemedicine aboard 300 aircraft
Nanowear announces partnership with Dexcom
Navina raises $55M to expand AI for value-based care

More Stories

Pharmacist interacting online
Serve You Rx, Amazon Pharmacy partner for home delivery
Two people shaking hands with six others watch
DarioHealth closes up to $50M debt refinancing and more funding news
Nurse consulting with patient
Teton unveils 3D hospital digital twin using Denmark's supercomputer
Young person communicating with a cell phone
Talkspace, Bark Technologies partner to monitor children's online activities
Pharmacist giving a person an injection
Plenful scores $50M and more funding news
Person interacting with a healthcare professional via tablet
Teladoc acquires UpLift for $30M, releases first quarter results
Person in a pharmacy setting
Hims & Hers, Novo Nordisk partner to offer weight-loss drug Wegovy
Healthcare professional looking at a PC screen
Commure, HealthTap partner for expanded after-hours care
Home

More News

  • Healthcare IT News
  • Healthcare IT News Australia
  • Healthcare Finance News
  • HIMSS TV

MobiHealthNews

 

Connect

Add MobiHealthNews to your network.
HIMSS25 European Health Conference & Exhibition
HIMSS25 European Health Conference & Exhibition
Get ready for knowledge-sharing, all the latest innovations, and in-depth demos with Europe's most influential healthcare community.
10 - 12 June, 2025 | Paris
Learn More
AI in Healthcare Forum
AI in Healthcare Forum
The HIMSS AI in Healthcare Forum cuts through the hype to showcase real-world examples illustrating the transformative potential, and realistic challenges of AI application across the care continuum.
10 - 11 July 2025 | New York
Learn More

Footer Menu

  • About
  • Advertise
  • Reprints
  • Contact
  • Privacy Policy

© 2025 MobiHealthNews is a publication of HIMSS Media

X

Topics

  • Video
  • Provider
  • Payer
  • Pharma
  • Consumer
  • Investor

Career

  • Events
  • Jobs
  • Learning Center

More

  • About
  • Advertise
  • Contact
  • Privacy Policy

Regions

  • ANZ
  • ASIA
  • EMEA
  • Global Edition

MobiHealthNews:

The latest news in digital health delivered daily to your inbox.

Search form

Top Stories

Smart phone and smart watch
Oura and Google Fitbit partner with academia and others to battle opioid disorder
Three surgeons operating on a patient
Thyroid cancer AI assistant developed in Hong Kong
A doctor discussing findings with an older patient
Digital dementia support project gets $2M federal funding and more briefs